We are live on ! Find out more
HIM

Hillsdale Investment Management Portfolio holdings

AUM $4.39B
1-Year Est. Return 72.96%
This Fund
S&P 500
This Quarter Est. Return
+16.61%
1 Year Est. Return
+72.96%
3 Year Est. Return
+270.97%
5 Year Est. Return
+506.63%
10 Year Est. Return
+3,190.25%
AUM
$2.71B
AUM Growth
+$742M
Cap. Flow
+$455M
Cap. Flow %
16.78%
Top 10 Hldgs %
23.89%
Holding
728
New
135
Increased
250
Reduced
157
Closed
115

Top Buys

Rank Stock Value
1
EMA
Emera Inc
EMA
+$42.5M
2
ARIS
Aris Mining
ARIS
+$28.3M
3
B
Barrick Mining
B
+$26.4M
4
AAPL icon
Apple
AAPL
+$24M
5
MSFT icon
Microsoft
MSFT
+$22.9M

Top Sells

Rank Stock Value
1
MEOH icon
Methanex
MEOH
+$36.9M
2
EFXT
Enerflex
EFXT
+$35.1M
3
ORLA
Orla Mining
ORLA
+$25M
4
VRN
Veren
VRN
+$19.7M
5
MFC icon
Manulife Financial
MFC
+$19.6M

Sector Composition

Rank Sector Weight
1 Financials 23.94%
2 Technology 18.75%
3 Materials 14.21%
4 Industrials 9.07%
5 Consumer Discretionary 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTA icon
576
Intapp
INTA
$3.05B
$6.19K ﹤0.01%
120
ENSG icon
577
The Ensign Group
ENSG
$10.6B
$6.17K ﹤0.01%
40
-10
-20% -$1.4K
XPER icon
578
Xperi
XPER
$321M
$6.17K ﹤0.01%
+780
New +$5.88K
CRMD icon
579
CorMedix
CRMD
$557M
$6.16K ﹤0.01%
+500
New +$5.52K
WTS icon
580
Watts Water Technologies
WTS
$12.9B
$6.15K ﹤0.01%
+25
New +$5.62K
DCTH icon
581
Delcath Systems
DCTH
$594M
$6.12K ﹤0.01%
+450
New +$6.27K
SBCF icon
582
Seacoast Banking Corp of Florida
SBCF
$3.44B
$6.08K ﹤0.01%
220
-30
-12% -$741
XERS icon
583
Xeris Biopharma Holdings
XERS
$1.55B
$6.07K ﹤0.01%
1,300
+200
+18% +$916
LTH icon
584
Life Time Group Holdings
LTH
$9.79B
$6.07K ﹤0.01%
200
AROC icon
585
Archrock
AROC
$5.84B
$5.96K ﹤0.01%
240
VIAV icon
586
Viavi Solutions
VIAV
$10.6B
$5.94K ﹤0.01%
590
BLND icon
587
Blend Labs
BLND
$331M
$5.94K ﹤0.01%
1,800
SXT icon
588
Sensient Technologies
SXT
$5.55B
$5.91K ﹤0.01%
60
-20
-25% -$1.79K
CDNA icon
589
CareDx
CDNA
$2.45B
$5.86K ﹤0.01%
300
-183,650
-100% -$3.26M
HWC icon
590
Hancock Whitney
HWC
$6.34B
$5.74K ﹤0.01%
100
-20
-17% -$1.06K
KRMD icon
591
KORU Medical Systems
KRMD
$152M
$5.73K ﹤0.01%
1,600
-61,900
-97% -$176K
VCYT icon
592
Veracyte
VCYT
$3.59B
$5.68K ﹤0.01%
210
NMRK icon
593
Newmark Group
NMRK
$2.63B
$5.47K ﹤0.01%
450
-50
-10% -$559
MOG.A icon
594
Moog Inc Class A
MOG.A
$13.6B
$5.43K ﹤0.01%
30
-10
-25% -$1.75K
SMTC icon
595
Semtech
SMTC
$13B
$5.42K ﹤0.01%
120
FRME icon
596
First Merchants
FRME
$2.72B
$5.36K ﹤0.01%
140
-20
-13% -$740
CNS icon
597
Cohen & Steers
CNS
$4.36B
$5.28K ﹤0.01%
70
UMBF icon
598
UMB Financial
UMBF
$11.4B
$5.26K ﹤0.01%
50
-10
-17% -$997
AVNS
599
DELISTED
Avanos Medical
AVNS
$4.9K ﹤0.01%
400
VVX icon
600
V2X
VVX
$2.55B
$4.86K ﹤0.01%
100

Similar funds

Hillsdale Investment Management's Q2 2025 Portfolio in Review

As of Q2 2025, Hillsdale Investment Management held 728 positions worth $2.71B, up 38% from $1.97B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Hillsdale Investment Management deployed $455M of net new capital in Q2 2025, opening 135 new positions and adding to 250 existing holdings. Its largest new stake was Emera Inc: 946,507 shares worth $43.4M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 27% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Enerflex, an estimated $35.1M trimmed.

  • Hillsdale Investment Management's largest Q2 2025 buy was Emera Inc: 946,507 shares worth $43.4M.
  • Hillsdale Investment Management added most to Barrick Mining in Q2 2025, an estimated $26.4M increase.
  • Hillsdale Investment Management's biggest Q2 2025 reduction was Enerflex, cutting an estimated $35.1M.
  • Hillsdale Investment Management fully exited Methanex in Q2 2025, selling an estimated $36.9M.
  • Hillsdale Investment Management's ten largest holdings make up 24% of its $2.71B portfolio in Q2 2025.
  • Hillsdale Investment Management opened 135 new positions and closed 115 in Q2 2025.
  • Hillsdale Investment Management's portfolio value rose 38% quarter-over-quarter to $2.71B.

Based on Hillsdale Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.